Furthermore, PTEN deletion maintains the sensitivity of tumor cells to chemotherapy by negatively regulating the PI3K‐AKT‐MDM2 pathway to promote the stability and transcriptional activity of p53 [53, 55]. The gene discussed is AKT1; the disease is neoplasm.